ReWalk Robotics Ltd. (NASDAQ:RWLK) shares rose 11.2% during mid-day trading on Thursday . The stock traded as high as $7.85 and last traded at $7.23, with a volume of 243,625 shares. The stock had previously closed at $6.50.

RWLK has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Tuesday, May 10th. Jefferies Group restated a “buy” rating and issued a $16.00 price objective on shares of ReWalk Robotics in a report on Sunday, May 8th. Finally, Piper Jaffray Cos. started coverage on ReWalk Robotics in a report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. ReWalk Robotics has an average rating of “Buy” and an average price target of $12.80.

The firm’s 50 day moving average price is $6.72 and its 200-day moving average price is $8.57. The company’s market capitalization is $84.99 million.

ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.64) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by $0.11. The business had revenue of $0.82 million for the quarter, compared to analysts’ expectations of $1.95 million. The firm’s quarterly revenue was up 34.4% compared to the same quarter last year. Analysts anticipate that ReWalk Robotics Ltd. will post ($2.11) EPS for the current fiscal year.

In other ReWalk Robotics news, Director Wayne Weisman sold 16,148 shares of the firm’s stock in a transaction on Friday, May 20th. The shares were sold at an average price of $9.09, for a total value of $146,785.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeff Dykan sold 11,370 shares of the firm’s stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total transaction of $88,003.80. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.